Successful use of femoral nerve block with dexmedetomidine for fracture fixation of an intracapsular fracture of the femoral neck in a patient with severe aortic stenosis: a case report
JA Clinical Reports volume 3, Article number: 53 (2017)
We described a case in which femoral nerve block (FNB) and lateral femoral cutaneous nerve block (LFCNB) with dexmedetomidine (DEX) was useful for open reduction and internal fixation (ORIF) of a femoral neck fracture in a patient with severe aortic stenosis. Cardiac surgery had been recommended but was declined by the patient. Thus, ORIF was selected because of the patient’s concomitant severe aortic stenosis. The anesthesia method used was FNB plus LFCNB with DEX, which achieved adequate local anesthesia. DEX was used to avoid respiratory depression because this patient has pulmonary hypertension. This patient had been sedative up to the end of surgery. Total operating time was 51 min, and the patient’s hemodynamics were stable throughout the perioperative period. There were no complications. In this case, anesthesia using a nerve block with DEX contributed to the safety of noncardiac surgery in a patient with severe cardiac disease under conservative treatment during the perioperative period.
In the emergency setting, we sometimes encounter the patients with coexisting severe comorbidities, especially cardiovascular disease. Emergency operation is a priority if cardiac surgery is recommended for these patients according to the 2014 American Heart Association/American College of Cardiology (AHA/ACC) guideline for management of patients with valvular heart disease . In such cases, selection of the anesthesia method and monitoring is important for hemodynamic stability during the perioperative period. Here, we report a case in which femoral nerve block with dexmedetomidine (DEX) was useful for open reduction and internal fixation (ORIF) of a femoral neck fracture in a patient with severe aortic stenosis using the Flotrac/Vigileo system.
A 68-year-old woman (body weight, 45 kg; height, 145 cm) fell while walking and visited our hospital with a chief complaint of hip pain. She had a history of hypertension, diabetes mellitus, aortic stenosis, atrial fibrillation, and schizophrenia. She lived in a care home, and detailed information was unavailable due to difficulty contacting her family. Previously, she had been hospitalized three times with a chief complaint of dyspnea. Cardiac surgery had been recommended but was declined by the patient.
On admission, her hemodynamics were stable, and there were no subjective or objective symptoms except for hip pain. After a detailed investigation, she was diagnosed as having intracapsular fracture of the femoral neck. Transthoracic echocardiography performed in the department of cardiovascular medicine showed an aortic valve area of 0.7 cm2 (aortic valve index, 0.49), aortic valve maximum pressure gradient of 96 mmHg, aortic regurgitation, and ejection fraction of 40%. And tricuspid regurgitation pressure gradient was 43 mmHg. Preoperative hemoglobin level was 8 g/dL. Based on these findings, she was diagnosed as having severe aortic stenosis.
Although bipolar hip arthroplasty was initially planned, ORIF was selected because of the patient’s concomitant severe aortic stenosis. The anesthesia method used was femoral nerve block with DEX. She was monitored using 5-lead electrocardiography and pulse oximetry. Continuous arterial pressure was measured after inserting a catheter into the radial artery. A PreSep Oximetry Catheter (Edwards Lifesciences, Irvine, CA, USA) was inserted via right jugular vein to measure central venous pressure (CVP) and central venous O2 saturation (ScvO2), and hemodynamic monitoring was performed using the FloTrac/Vigileo system (Edwards Lifesciences, Irvine, CA, USA). Hemodynamic values, including the cardiac index (CI), mean arterial pressure (MAP), heart rate (HR), CVP, systemic vascular resistance index (SVRI), stroke volume index (SVI), and ScvO2, were measured. Femoral nerve block was performed using a linear ultrasound probe (HFL50 15–6 MHz; SonoSite Inc., Bothell, WA, USA) and a 5-cm, 18-gauge Contiplex Tuohy needle (B-Braun Ltd., Tochigi, Japan) . A 22-mL dose of ropivacaine 0.2% was injected around the femoral nerve, and the lateral femoral cutaneous nerve block (LFCNB) was achieved with a 10-mL dose of ropivacaine 0.2%. After obtaining adequate local anesthesia, DEX administration and surgery were started simultaneously. Sedative level was decided by the Observer’s Assessment of Alertness/Sedation (OAA/S) score. The dose of DEX was adjusted within the range of 0.2–0.7 μg/kg/h by using OAA/S score. Sedative level was 3 and PaCO2 was 39.3 mmHg at the conclusion of surgery. However, the patient showed signs of distress when operating on the femoral head, for which fentanyl 25 μg was administered four times. Total operating time was 51 min, and anesthesia time was 100 min. Total blood loss was 20 g, total fluid valance was + 230 mL, and wound length was 10 cm. The patient’s hemodynamics remained stable during the perioperative period (Table 1).
After surgery, the patient was transferred to the intensive care unit while DEX was continued. Then, the dose of DEX was gradually tapered. Acetaminophen 1000 mg was administered for postoperative pain, after which there was no complaint of pain. She was transferred to the general ward a day after the surgery, and her hemodynamics remained stable throughout the perioperative period.
We described a case of anesthesia management for ORIF in a 68-year-old patient with various comorbidities, including severe aortic stenosis.
In this case, the patient was diagnosed as having severe aortic disease. According to the 2014 American Heart Association/American College of Cardiology (AHA/ACC) guideline for management of patients with valvular heart disease, aortic valve replacement is recommended as a class I treatment in patients with severe aortic stenosis . ORIF was scheduled after obtaining informed consent and explaining the risks of untreated aortic stenosis. Severe aortic stenosis is associated with increased risk in noncardiac surgery, depending on the degree of aortic valve and left ventricular systolic function . It was necessary to pay attention to fluid balance . We used CVP to assess preload. Because this patient was spontaneously breathing, we could not use minimally invasive monitoring such as stroke volume variation.
We chose femoral nerve block plus DEX as the anesthetic method. We determined that hemodynamic stability was high on the patient’s list of priorities, because the psychiatric disorder was well controlled. In general, ORIF is performed under general or spinal-epidural anesthesia. Wood et al. examined the effects of anesthesia on intraoperative blood pressure and reported higher incidences of intraoperative hypotension with both general anesthesia (34.2%) and spinal-epidural anesthesia (29.7%) . A femoral nerve block has a smaller effect on hemodynamic parameters than spinal-epidural anesthesia. This hemodynamic instability with spinal-epidural anesthesia is mainly induced by the sympathetic block [4,5,6]. For patients with severe aortic stenosis, it is important to maintain afterload in order to preserve coronary artery blood flow . Otherwise, the vasodilating effects of anesthesia decrease afterload and cause hypotension. As a result, increased pressure gradient between the left ventricle and aorta may aggravate the myocardial oxygen demand-supply balance. We assessed afterload by evaluating SVRI. And SVRI had been stable during surgery.
Sedation was obtained with continuous administration of DEX in this patient because she had a concomitant psychiatric disorder and was expected to be unable to remain immobile during surgery . DEX has been reported to induce hypercapnia . In this study, however, although hypercapnia occurred after administration of intravenous 1.0 and 2.0 μg/kg DEX over a 2-min period, hypercapnia did not occur after administration of 0.25 and 0.5 μg/kg DEX. Otherwise, this case was administered DEX at 0.4–0.7 μg/kg/h without a loading dose, and the total DEX dose was within 0.6 μg/kg during the operation. Chang et al. reported that DEX produced less respiratory depression than propofol and midazolam in a sevoflurane-anesthetized rabbit CO2 inhalation model . Accordingly, DEX was used to avoid hypercapnia due to respiratory depression because the patient had pulmonary hypertension. Alternatively, low-dose administration of DEX has been reported to elicit obstructive apnea ; moreover, fentanyl can lead to hypercapnia. In this case, however, DEX and fentanyl did not lead to hypercapnia (Table 1), and we believed that an additional local block would be useful. This case was sedated well, and hypercapnia was avoided. Hypotension is the primary significant side effect of DEX, which may be mitigated by avoiding a loading dose or initiating a slow infusion rate. In this patient, hemodynamic stability was a priority over her psychiatric disorder, so the DEX infusion was started without a loading dose . Although continuous administration of DEX may decrease heart rate , this effect was considered to be rather advantageous for maintaining hemodynamics because she had concomitant atrial fibrillation and aortic stenosis. Lønnebakken et al. reported that a low SVI is associated with an increased cardiovascular mortality and high HR. The ACC/AHA guideline recommends avoiding tachycardia and hypotension in patients with coexisting aortic stenosis, so we maintained HR, SVI, and SVRI using the FloTrac/Vigileo system during the perioperative period . She had anemia, so we monitored not only SVI but ScvO2 to assess oxygen supply/demand balance. We used additional 25 μg fentanyl four times when operative pain stimulation extended to the acetabuli, because the acetabuli received innervation from not only the femoral nerve but also the sciatic nerve. Although fentanyl was effective in controlling pain in this case, we believed that combining it with a sciatic nerve block would also be useful.
Femoral nerve block with DEX was performed for noncardiac surgery in a patient with severe aortic stenosis. Her hemodynamics remained stable throughout the perioperative period, and there were no complications. In this case, anesthesia using a nerve block with DEX under hemodynamic monitoring contributed to the safety of noncardiac surgery in a patient with severe cardiac disease under conservative treatment during the perioperative period.
Association/American College of Cardiology
Central venous pressure
Femoral nerve block
Lateral femoral cutaneous nerve block
Mean arterial pressure
Observer’s Assessment of Alertness/Sedation
Open reduction and internal fixation
- ScvO2 :
Central venous saturation
Stroke volume index
Systemic vascular resistance index
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-185.
Marhofer P, Greher M, Kapral S. Ultrasound guidance in regional anaesthesia. Br J Anaesth. 2005;94:7–17.
Wood RJ, White SM. Anaesthesia for 1131 patients undergoing proximal femoral fracture repair: a retrospective, observational study of effects on blood pressure, fluid administration and perioperative anaemia. Anaesthesia. 2011;66:1017–22.
Fanelli G, Casati A, Aldegheri G, Beccaria P, Berti M, Leoni A, Torri G. Cardiovascular effects of two different regional anaesthetic techniques for unilateral leg surgery. Acta Anaesthesiol Scand. 1998;42:80–4.
Xu J, Chen XM, Ma CK, Wang XR. Peripheral nerve blocks for postoperative pain after major knee surgery. Cochrane Database Syst Rev. 2014:CD010937.
Gerrard AD, Brooks B, Asaad P, Hajibandeh S, Hajibandeh S. Meta-analysis of epidural analgesia versus peripheral nerve blockade after total knee joint replacement. Eur J Orthop Surg Traumatol. 2017;27:61–72.
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278–333.
Ng AT, Ip-Yam PC. Epidural anesthesia with intravenous dexmedetomidine sedation in the successful anesthetic management of MRI-guided focused ultrasound ablation of early prostatic cancer. J Anesth. 2011;25:756–9.
Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–33.
Chang C, Uchiyama A, Ma L, Mashimo T, Fujino Y. A comparison of the effects on respiratory carbon dioxide response, arterial blood pressure, and heart rate of dexmedetomidine, propofol, and midazolam in sevoflurane-anesthetized rabbits. Anesth Analg. 2009;109:84–9.
Ono C, Sugita M, Ikuta Y, Yamamoto T. Even low doses of dexmedetomidine produced obstructive apnea during spinal anesthesia. Can J Anaesth. 2017; doi: 10.1007/s12630-017-0960-7. [Epub ahead of print]
Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med. 2012;185:486–97.
Abdallah FW, Abrishami A, Brull R. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia: a systematic review and meta-analysis. Anesth Analg. 2013;117:271–8.
Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. Heart. 2017; [Epub ahead of print]
Written informed consent was obtained from the patient and her family to publish this case report and accompanying images.
TO contributed to the study conception and design. KK and SS contributed to the data acquisition. YY and TO contributed to the drafting of the article. YY contributed to the critical revision of the article for important intellectual content. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yamane, Y., Omae, T., Kou, K. et al. Successful use of femoral nerve block with dexmedetomidine for fracture fixation of an intracapsular fracture of the femoral neck in a patient with severe aortic stenosis: a case report. JA Clin Rep 3, 53 (2017). https://doi.org/10.1186/s40981-017-0126-1
- Femoral nerve block
- Aortic stenosis